Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Jane Frances Lunkuse

Datos Biográficos

ID7730767
NOMBREJane Frances Lunkuse
NOMBRESJane Frances
APELLIDOLunkuse
FIRMALUNKUSE J F
AFILIACIONESUganda Virus Research Institute
ORCID0000-0003-1261-2699
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2024
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • Willingness of adolescent girls and young women to participate in future clinical trials of long-acting PrEP implants for HIV prevention, Kampala Uganda

    Open Access•Jane Frances Lunkuse, Grace Godfrey Sseremba et al.•ARTICLE•PLOS Global Public Health•2025

    Adolescent girls and young women (AGYW) continue to face a significant risk of HIV infection, particularly as numerous experimental prevention products are in development. This study assessed the willingness to participate (WTP) in future clinical trials of long-acting HIV pre-exposure prophylaxis (PrEP) implants among AGYW at high risk of HIV infection in Kampala, Uganda. From January to October 2019, we conducted a cross-sectional study among A…

  • Willingness to Use Long-Acting Injectable Pre-Exposure Prophylaxis among Adolescent Girls and Young Women in Kampala, Uganda

    Open Access•Jane Frances Lunkuse, Charles Lwanga et al.•ARTICLE•AIDS and Behavior•2025

    Pre-exposure prophylaxis (PrEP) has proven to be a powerful tool in preventing HIV infection. There is limited information about the factors associated with willingness to use different PrEP modalities among adolescent girls and young women (AGYW) in Africa. We assessed willingness to use long-acting injectable PrEP (LAI-PrEP) among 14-24-year-old AGYW at high risk of HIV in Uganda, and associated factors determined using multivariable complement…

  • Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda

    Open Access•Yunia Mayanja, Ivy Kayesu et al.•ARTICLE•Frontiers in Public Health•2024

    Background Novel HIV pre-exposure prophylaxis (PrEP) methods including a potential future HIV vaccine, will increase prevention options for adolescent girls and young women (AGYW) at high risk of HIV infection in Eastern and Southern Africa, yet data on AGYW’s preferences for various PrEP methods is limited. We investigated preferences for five biomedical PrEP methods (oral, injectable, vaginal ring, implant, HIV vaccine) among 14–24-years-old AG…

  • Prevalence and factors associated with illicit drug and high-risk alcohol use among adolescents living in urban slums of Kampala, Uganda

    Open Access•Hellen Kalungi, Onesmus Kamacooko et al.•ARTICLE•BMC Public Health•2024

    Illicit drug and high-risk alcohol use are prevalent among male adolescents and adolescents involved in high-risk sexual behavior living in the urban slums of Kampala

Sin obras prominentes en esta página.

  • Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda

    Open Access•Yunia Mayanja, Ivy Kayesu et al.•ARTICLE•Frontiers in Public Health•2024

    Background Novel HIV pre-exposure prophylaxis (PrEP) methods including a potential future HIV vaccine, will increase prevention options for adolescent girls and young women (AGYW) at high risk of HIV infection in Eastern and Southern Africa, yet data on AGYW’s preferences for various PrEP methods is limited. We investigated preferences for five biomedical PrEP methods (oral, injectable, vaginal ring, implant, HIV vaccine) among 14–24-years-old AG…

  • Prevalence and factors associated with illicit drug and high-risk alcohol use among adolescents living in urban slums of Kampala, Uganda

    Open Access•Hellen Kalungi, Onesmus Kamacooko et al.•ARTICLE•BMC Public Health•2024

    Illicit drug and high-risk alcohol use are prevalent among male adolescents and adolescents involved in high-risk sexual behavior living in the urban slums of Kampala

  • Willingness of adolescent girls and young women to participate in future clinical trials of long-acting PrEP implants for HIV prevention, Kampala Uganda

    Open Access•Jane Frances Lunkuse, Grace Godfrey Sseremba et al.•ARTICLE•PLOS Global Public Health•2025

    Adolescent girls and young women (AGYW) continue to face a significant risk of HIV infection, particularly as numerous experimental prevention products are in development. This study assessed the willingness to participate (WTP) in future clinical trials of long-acting HIV pre-exposure prophylaxis (PrEP) implants among AGYW at high risk of HIV infection in Kampala, Uganda. From January to October 2019, we conducted a cross-sectional study among A…

  • Willingness to Use Long-Acting Injectable Pre-Exposure Prophylaxis among Adolescent Girls and Young Women in Kampala, Uganda

    Open Access•Jane Frances Lunkuse, Charles Lwanga et al.•ARTICLE•AIDS and Behavior•2025

    Pre-exposure prophylaxis (PrEP) has proven to be a powerful tool in preventing HIV infection. There is limited information about the factors associated with willingness to use different PrEP modalities among adolescent girls and young women (AGYW) in Africa. We assessed willingness to use long-acting injectable PrEP (LAI-PrEP) among 14-24-year-old AGYW at high risk of HIV in Uganda, and associated factors determined using multivariable complement…

Adolescent Sexual and Reproductive Health (4 obras) · Family medicine (4 obras) · Medicine (4 obras) · HIV/AIDS Research and Interventions (3 obras) · Internal Medicine (3 obras) · Pre-exposure prophylaxis (3 obras) · Chlamydia (2 obras) · Demography (2 obras) · Environmental health (2 obras) · Global Maternal and Child Health (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae